THE FDA is urging drug
manufacturers of combination
drugs which contain
acetaminophen to limit the
amount of the ingredient to no
more than 325mgs per tablet/
capsule.
It is hoped the move will
minimise the potential risk of liver
damage to users of pain and fever
drugs.
The FDA has also declared
manufacturers must update
product labels to reflect
acetaminophen’s potential to
cause severe liver damage.The above article was sent to subscribers in Pharmacy Daily's issue from 17 Jan 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Jan 11
AUSTRALIA needs more pharmacists than ever, in the face of an ageing population and rising healthcare demands, according to the Pharmaceutical Society of Australia (PSA).
INTERN pharmacists from Monash University are set to join Victoria’s immunisation workforce under a new Secretary Approval by the Victorian Health Department.
VIRTUAL care delivered through telephone or video conference has now embedded itself as a core component of healthcare delivery in NSW, new market reports released today have revealed.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.